|
Sanchez Barrueco A, Mateos-Moreno MV, Martinez-Beneyto Y, Garcia-Vazquez E, Campos Gonzalez A, Zapardiel Ferrero J, Bogoya Castano A, Alcala Rueda I, Villacampa Auba JM, Cenjor Espanol C, Moreno-Parrado L, Ausina-Marquez V, Garcia-Esteban S, Artacho A, Lopez-Labrador FX, Mira A, Ferrer MD. Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial. Emerg Microbes Infect. 2022 Dec;11(1):1833-1842. doi: 10.1080/22221751.2022.2098059. PubMed PMID: 35796097; PubMed Central PMCID: PMC9336498.
AÑO: 2022; IF: 13.2
|
35796097
|
Sabater Molina M, Nicolas Rocamora E, Bendicho AI, Vazquez EG, Zorio E, Rodriguez FD, Gil Ortuno C, Rodriguez AI, Sanchez-Lopez AJ, Jara Rubio R, Moreno-Docon A, Marcos PJ, Garcia Pavia P, Villa RB, Gimeno Blanes JR. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease. PLoS One. 2022 Feb 4;17(2):e0263140. doi: 10.1371/journal.pone.0263140. eCollection 2022. PubMed PMID: 35120165; PubMed Central PMCID: PMC8815985.
AÑO: 2022; IF: 3.7
|
|
Salas-Coronas J, Perez Perez A, Roure S, Sanchez Peinador C, Santos Larregola L, Arranz Izquierdo J, Bocanegra C, Garcia Lopez Hortelano M, Garcia Vazquez E, Moza Morinigo H, Azkune Galparsoro H. [Consensus document for the management of schistosomiasis in Primary Care]. Aten Primaria. 2022 Aug;54(8):102408. doi: 10.1016/j.aprim.2022.102408. Epub 2022 Jun 23. Spanish. PubMed PMID: 35753207; PubMed Central PMCID: PMC9249679.
AÑO: 2022; IF: 2.5
|
|
Pericas JM, Llopis J, Munoz P, Gonzalez-Ramallo V, Garcia-Leoni ME, de Alarcon A, Luque R, Farinas MC, Goenaga MA, Hernandez-Meneses M, Nicolas D, Ramos-Martinez A, Rodriguez-Esteban MA, Villoslada-Gelabert A, Miro JM; GAMES Investigators. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria. Open Forum Infect Dis. 2022 Aug 30;9(9):ofac442. doi: 10.1093/ofid/ofac442. eCollection 2022 Sep. PubMed PMID: 36172059; PubMed Central PMCID: PMC9512706.
AÑO: 2022; IF: 4.2
|
|
Sojo-Dorado J, Lopez-Hernandez I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernandez-Torres A, Merino de Lucas E, Escola-Verge L, Bereciartua E, Garcia-Vazquez E, Pintado V, Boix-Palop L, Natera-Kindelan C, Sorli L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martinez-Alvarez RM, Duenas CJ, Calvo-Montes J, Silva JT, Cardenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yague-Guirao G, Lobo-Acosta MA, Merino-Bohorquez V, Pascual A, Rodriguez-Bano J; REIPI-GEIRAS-FOREST group. Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277. PubMed PMID: 35024838; PubMed Central PMCID: PMC8759008.
AÑO: 2022; IF: 13.8
|